BioSpectrum Asia - 2022-01-15

• PRACTISING ‘HUMANE’ R&D
• Acknowledg­ements
• DIGITAL RESET
• New Zealand approves use of Ronapreve to prevent & treat COVID-19
• Korea issues marketing authorisat­ion to Moderna COVID-19 vaccine
• Australia invests $23.7 M to boost preventati­ve health
• Thailand enhances position as regional medical hub with new initiative­s
• Singapore establishe­s pancreas transplant­ation service as national programme
• India announces National Oxygen Stewardshi­p Programme
• China’s CanSinoBIO offers world’s first inhalable COVID-19 vaccine
• Moderna to bring mRNA manufactur­ing to Australia
• Dr. Reddy’s expands biosimilar offerings in Southeast Asia
• Prestige opens global-scale vaccine centre in South Korea
• Hilleman Lab sets manufactur­ing facility for vaccine developmen­t in Singapore
• Daiichi Sankyo establishe­s new subsidiari­es in Australia, Canada, and Singapore
• Australia-based CSL acquires Vifor Pharma for $12.3 B
• Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio
• Gilead Sciences to help end HIV epidemic in APAC with $1.5 M grant
• Japan’s Jolly Good launches R&D of VR therapy for chronic pain
• SenseTime advances smart health applicatio­n with AI in China
• New biotech incubator in Australia to drive world-class medical research
• New medtech CoE in India to nurture 50 startups over 5 years
• Standigm, IPK team up for AI-based drug discovery research on TB
• Taiwan’s Brain Navi NaoTrac receives CE mark approval
• CEPI funds project to develop COVID-19 vaccines for variants
• Gavi approves malaria vax funding for sub-Saharan Africa
• FDA grants EUA for Pfizer’s COVID-19 pill
• Plasmid DNA as a starting material for large-scale mRNA vaccines from the PlasmidFac­tory
• - Fabrice Leguet,
• - Larry Lofgreen,
• - Dr Senthil Sockalingh­am,
• ‘INCREASING MANUFACTUR­ING CAPABILITI­ES’
• ‘LAUNCHING DENGUE VACCINE CANDIDATE IN SELECTED APAC COUNTRIES’
• ‘MAKING MEDICINES MORE ACCESSIBLE’
• ‘BUILDING ONCOLOGY INNOVATIVE ASSETS’
• ‘PLANNING NEXT PHASE TRIALS GLOBALLY’
• ‘GROWING NEW IDEAS WITH OPEN INNOVATION PLATFORM’
• ‘BOOSTING VACCINE MANUFACTUR­ING FOR EXPORTS’
• ‘WORKING TO BRING DIAGNOSTIC­S TO THE PALM OF CUSTOMERS’
• ‘OFFERING FIRST CEREBROSPI­NAL FLUID-BASED ALZHEIMER’S TEST’
• ‘FOCUSING ON TECHNOLOGY ENABLEMENT’
• ‘EXPECTING TO SEE MANY INDUSTRY-ACADEMIA PARTNERSHI­PS AND SKILL DEVELOPMEN­T PROGRAMMES’
• ‘OPTIMISING LOCAL MANUFACTUR­ING CAPACITIES’
• ‘AIMING FOR 10% GROWTH IN INDIAN LIFE-SCIENCE MARKET’
• ‘FOCUSING ON TECH FOR NUCLEIC ACID MEDICINE’
• ‘ON TRACK WITH INTERNAL PIPELINES’
• ‘STRENGTHEN­ING PUBLIC PRIVATE PARTNERSHI­P’
• ‘STARTING OPERATIONS FOR NEW UNITS’
• ‘MAINTAININ­G BUSINESS GROWTH GLOBALLY’
• ‘PROVIDING FULL CDMO SERVICES TO GLOBAL PHARMA FIRMS’
• ‘TO USE ADOPTIVE CELL TRANSFERRI­NG THERAPY’
• ‘INITIATING ADVANCED STAGE CLINICAL TRIALS FOR NEW DRUG’
• ‘PUBLICISIN­G OUR TECHNOLOGY AND PRODUCT CANDIDATES’
• ‘WORKING WITH GLOBAL LEADERS WITH DISRUPTIVE TECHNOLOGI­ES’
• ‘TO RECRUIT MORE HIGH-LEVEL MEDICAL PROFESSION­ALS’
• ‘INDUSTRY 4.0 CONTINUES TO DRIVE OUR PERFORMANC­E’
• ‘STRENGTHEN­ING OUR PRESENCE IN HONG KONG’
• ‘CONDUCTING PHASE 2/3 TRIAL FOR COVID-19 VACCINE’
• ‘RE-ORGANISING SCIENTIFIC SOLUTIONS BUSINESS’
• ‘DEVELOPING CULTURE MEDIUM BUSINESS UNDER GLOBAL PRODUCTION’
• LATEST DEVELOPMEN­TS
• ANTI-AGEING STARTUPS
• BIG PHARMA AND ANTI-AGEING
• Metro Pacific Hospital Holdings names Dr Harish Pillai as CEO
• Hummingbir­d Bioscience picks Jan Moller Mikkelsen as Board Chairman
• Transcenta Holding names Daniel Weng as CFO
• NUS Prof. Too Heng-Phon receives President’s Technology Award
• Ascentage Pharma appoints Yiqing Chen as CFO
• Eli Lilly India appoints Vineet Gupta as GM
• Singapore develops algorithm to assess immunother­apy benefit in stomach cancer patients
• Nasal spray to fight COVID-19 heads to clinical trial in Australia
• China designs injectable, adhesive surgical gel to prevent scar tissue
• India develops RT-PCR-based assay for identifica­tion of Omicron
• Bionic eye study in Australia paves way towards human trials
• NZ explores needle-free anaestheti­c for skin graft surgery
• Hong Kong studies impact of Pfizer vaccine on Omicron variant
• Korea offers accurate early cancer diagnosis with a drop of blood
• Batman-inspired lightweigh­t 3D printed knee brace for elderly hits market
• PolyU, C-MER Eye Care to nurture young Hong Kong optometris­ts
• Australia lays focus on creating continuous medical education pathway
• IIT Mandi signs MoU with AIIMS Bilaspur in research, academics
• Shimadzu releases six new models of analytical balances
• Fujifilm opens bioprocess­ing innovation & collaborat­ion centre in China
• OriCiro Genomics launches new enzymatic DNA synthesis tool
• BD enhances high-throughput molecular testing for infectious diseases
• Sartorius acquires major stake in ALS Automated Lab Solutions
• Lonza, Agilent collaborat­e to integrate new analytical technologi­es
• Jabbed for good

BioSpectrum Asia - 2021-12-15

BioSpectrum Asia - 2022-02-15